Novavax Stock Slides 30% as Revenue Guidance for 2022 Is Slashed
Textual content dimension Novavax slashed its income steerage for 2022. Karen Ducey/Getty Photos Novavax slumped greater than 30% early Tuesday after the Covid-19 vaccine maker slashed its steerage for 2022 ...